Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system by Cooper, Cathleen L. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
1997-05-01 
Expression of the Id family helix-loop-helix regulators during 
growth and development in the hematopoietic system 
Cathleen L. Cooper 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Cancer Biology Commons 
Repository Citation 
Cooper CL, Brady G, Bilia F, Iscove NN, Quesenberry PJ. (1997). Expression of the Id family helix-loop-helix 
regulators during growth and development in the hematopoietic system. Open Access Articles. Retrieved 
from https://escholarship.umassmed.edu/oapubs/288 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
1997 89: 3155-3165
 
 
 
 
 
Cathleen L. Cooper, Gerard Brady, Fillio Bilia, Norman N. Iscove and Peter J. Quesenberry 
 
and Development in the Hematopoietic System 
Expression of the Id Family Helix-Loop-Helix Regulators During Growth
 http://bloodjournal.hematologylibrary.org/cgi/content/full/89/9/3155
Updated information and services can be found at: 
 (2346 articles)Hematopoiesis 
 collections: BloodArticles on similar topics may be found in the following 
 http://bloodjournal.hematologylibrary.org/misc/rights.dtl#repub_requests
Information about reproducing this article in parts or in its entirety may be found online at: 
 http://bloodjournal.hematologylibrary.org/misc/rights.dtl#reprints
Information about ordering reprints may be found online at: 
 http://bloodjournal.hematologylibrary.org/subscriptions/index.dtl
Information about subscriptions and ASH membership may be found online at: 
. Hematology; all rights reservedCopyright 2007 by The American Society of 
DC 20036.
by the American Society of Hematology, 1900 M St, NW, Suite 200, Washington 
Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published semimonthly
 
 
 
 
 For personal use only. at UNIV OF MASSACHUSETTS on April 3, 2008. www.bloodjournal.orgFrom 
Expression of the Id Family Helix-Loop-Helix Regulators During Growth
and Development in the Hematopoietic System
By Cathleen L. Cooper, Gerard Brady, Fillio Bilia, Norman N. Iscove, and Peter J. Quesenberry
To better understand the molecular mechanism(s) by which was downregulated in cells of increasing maturity; con-
growth and differentiation of the primitive hematopoietic versely, Id-2 and, to a limited extent, Id-3 gene expression
stem cell is initiated, as well as the means by which the increased as cells matured and lost proliferative capacity.
maturing cell can commit to development along a specific Id-2 expression ran counter to that of Id-1 not only during
cell lineage, we elected to study the Id family of helix-loop- maturation, but during periods of cell growth and arrest as
helix (HLH) transcriptional regulators. Some members of the well. This is quite distinct from the nonhematopoietic tis-
HLH family are expressed in a stage-specific manner during sues, in which these two factors are coordinately expressed
hematopoietic development and can regulate the ability of and suggests that Id-1 and Id-2 might be regulating very
immature hematopoietic cells to terminally differentiate. different events during hematopoiesis than they regulate in
None of the four Id family genes were detected in the most other cell types.
primitive progenitors. Id-1 was widely expressed in prolifer- q 1997 by The American Society of Hematology.
ating bi- and unipotential progenitors, but its expression
main that affects transcriptional activation once the activeA dimer has been localized to its correct position in a promoterPOOL OF PRIMITIVE hematopoietic stem cells(PHSC) reside in the adult bone marrow as a reservoir
or enhancer regulatory unit.22,30,31 There are variants thatof uncommitted and undifferentiated blood cell precursors.
function as negative regulators as well. In some instances,In order to maintain an appropriately balanced system, these
alternative splicing generates HLH monomers lacking thecells must respond to cues from the extracellular environ-
transactivation region; heterodimerization between thisment by proliferation and subsequent differentiation into ma-
monomer and a full-length HLH activator would be expectedture cell types. Each stage of this process, from the initial
to decrease or extinguish the activation potential of the resul-activation of the resting G0 stem cell through the critical
tant dimer.32 Alternately, there is a subclass of HLH formsevent of lineage commitment to the final stages of differenti-
that completely lack the basic DNA binding region. Theseation is ultimately controlled by the amounts and types of
proteins make up the Id (inhibitor of DNA binding) family,transcriptional regulators expressed in the cell. Members of
which can heterodimerize with HLH members to form di-the helix-loop-helix (HLH),1 the homeobox (Hox),2-4 basic-
mers containing an incomplete DNA binding region, whichzipper (bZ),5,6 LIM,7,8 and zinc finger9,10 transcription factor
then cannot bind to DNA.26,27,33,34 These Id family proteinsfamilies have been detected in cells during some stage(s) of
act through sequestration of the HLH activators in nonfunc-hematopoietic development. Thus, members of any of these
tional complexes.groups could potentially play a role in the regulation of some
In addition to these structural classifications, HLH familyor all of the key developmental switch points that must be
regulators are subdivided according to their expression pat-negotiated in order for a normal blood cell to mature.
terns. Some regulators are widely expressed, such as theThe HLH family of transcriptional regulators may play
universal E protein family (eg, E2A, E2-2, HEB; also calledan important role in hematopoiesis. Members of this family
class I proteins); other class II factors are expressed in ahave been shown to be key players in the regulation of neural
tissue-restricted fashion (eg, MyoD and myogenin in muscledevelopment,11,12 sex determination,12 and myogenesis,13,14
tissue; SCL and lyl-1 in hematopoietic cells).1,35 Class IIIas well as to contribute to regulation of development in the
proteins, such as the Id family of negative regulators, showpancreas,15 bone,16,17 and fatty tissue.18 There is evidence to
an intermediate pattern of distribution.26,27,33,34 Most impor-suggest that this family may control hematopoietic develop-
tantly, many of these regulators are highly expressed in nor-ment as well.1,4,19-24 Numerous HLH regulators, including
mal hematopoietic tissues during the stage in which theseE47/E12,1,4,24 SCL,1,4,25 lyl-1,1,4,22 and most of the Id fac-
tors4,26-28 have been identified in at least a subset of normal
hematopoietic tissues and cell lines. These regulators include
From the Department of Medicine University of Massachusettsboth known transcriptional activators (eg, E12/E47 and SCL)
Cancer Center, Worcester, MA; and Ontario Cancer Institute, To-
as well as transdominant negative regulators (eg, the Id pro-
ronto, Ontario.
teins). Submitted September 16, 1996; accepted December 5, 1996.
The function of HLH transcriptional regulators is dictated Supported by Grant No. CA 27466 to P.J.Q. from the National
by three structural elements: (1) the HLH protein dimeriza- Institutes of Health and by operating grants to N.N.I. from the Na-
tion interface, (2) a basic DNA binding region, and (3) an tional Cancer Institute of Canada and the Medical Research Council
of Canada.N-terminal transactivation domain. The HLH structure is a
Address reprint requests to Cathleen L. Cooper, PhD, Universityprotein dimerization motif that is used to combine HLH
of Massachusetts Cancer Center, 373 Plantation St, Suite 202,monomer subunits into functionally important dimers.29 Up-
Worcester, MA 01605.stream and extending from helix one there is usually a basic
The publication costs of this article were defrayed in part by page
region, which is a DNA binding half-site. When these pro-
charge payment. This article must therefore be hereby marked
teins dimerize they juxtapose the two half-sites into an active
‘‘advertisement’’ in accordance with 18 U.S.C. section 1734 solely to
DNA-binding element that can then recognize and bind to indicate this fact.
specific sequence motifs called E-boxes. Finally, in some of q 1997 by The American Society of Hematology.
0006-4971/97/8909-0001$3.00/0these molecules, there is an N-terminal transactivation do-
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3-conditioned medium (WEHIcm). NFS60 and FDCP1 cells werecells must be able to respond to the external signaling that
routinely grown in RPMI 1640/10% HI-FCS supplemented withcontrols their ability to continue proliferation or commit to
10% or 25% WEHI3cm, respectively.differentiate into a mature blood cell.1,4
Both class I and class II factors have been demonstrated
Cell-Cycle Synchronizationto be essential for normal hematopoietic development. Mice
Cells growing actively in early- to mid-log phase were preculturedlacking the class I gene E2A have a complete block in B
for 36 hours in isoleucine-deficient medium (isoleucine-deficientcell development while other hematopoietic lineages remain
DMEM supplemented with 10% dialyzed HI-FCS and 25% dialyzedlargely normal.24,36 Blood development is profoundly limited
WEHIcm) to arrest their growth. After that time, one half of thein mice lacking the class II SCL gene; embryos suffer a
cells were resuspended in complete growth medium (DMEM plus
complete block in early erythropoiesis with virtual absence 25% WEHIcm and 10% HI-FCS) while the control cells were resus-
of myeloid cells, suggesting that this gene is essential for pended in DMEM plus 10% HI-FCS only. Cells were grown for 48
normal growth and development of early myelo-erythroid hours, during which time samples from both cytokine replete and
progenitor cells.37 A working model for the role of HLH control populations were withdrawn for RNA preparation44 and sam-
factors in differentiation proposes that the ability of a cell ples from the cytokine-replete proliferating population removed for
analysis of cell cycle progression by 3H-thymidine uptake.45 Addi-to differentiate may be controlled at the transcriptional level
tionally, cell growth and viability was monitored by cell counts andby a heterodimer between a class II tissue-specific HLH
trypan blue exclusion.factor and a member of the class I E proteins.38 This hetero-
dimer would then be able to activate expression of genes
Cytokine Starvation Experimentsrequired for maturation. The action of this dimer is nega-
FDCPI cells were cultured in RPMI 1640 supplemented with 25%tively regulated by the class III Id family, which can prevent
WEHIcm and 10% FCS. For cytokine-response studies, these cellsdifferentiation by sequestration of class I E proteins in non-
were starved of growth factors by culture in RPMI plus 0.5% HI-functional complexes.40 Since most tissue-specific class II
FCS for 24 hours before transfer into fresh medium supplementedproteins only function as heterodimeric complexes with the
recombinant murine (rm) IL-3 (Collaborative Research, Waltham,class I proteins,35,41-43 this prevents tissue-specific factors
MA) or rmGM-CSF (Amgen, Thousand Oaks, CA) at 100 U/mLfrom initiating the maturation process.
each. In each case, maximal cell growth stimulation was predeter-In a previous study, we surveyed the expression patterns
mined by a dose-response titration of the individual growth factor
of several HLH transcriptional regulators (eg, E12/E47, (not shown); a concentration of each factor that gave maximal
SCL, ly1-1, and Id-1) in proliferating hematopoietic cells growth response was selected for use in each of these experiments.
and cell lines.4 This work identified developmental stage- Samples were removed for RNA analysis at multiple time points
after cytokine stimulation.specific and cell cycle-related variations in expression of
these genes, particularly Id-1. Since Id-1 belongs to a family
RNA Isolation and Analysisof at least four similar transdominant negative regulators,
we first needed to study the expression of Id-1 in the context Ten micrograms of unselected cytoplasmic RNA44 from each time
of the other four family members in order to determine which point was separated by electrophoresis on a formaldehyde gel before
transfer to Hybond N membrane. Each filter was hybridized to 32P-Id family gene might be functionally important for regulating
random labeled Id gene probes. After a high stringency wash, filtersdifferent aspects of hematopoietic growth and development.
were exposed to film and the specific bands later quantitated on aTo do this, we first determined the range of expression of
PhosphorImager (Molecular Dynamics, Sunnyvale, CA). To normal-all four Id family genes in hematopoietic cells and tissues
ize for loading efficiency each filter was stripped and rehybridizedduring growth and differentiation, then assayed whether the
to a 28S ribosomal RNA probe46 or a GAPDH probe47 as indicated.
expression of some or all of these genes was specifically Id-1 was quantitated after a 24-hour exposure; Id-2 quantitated after
modulated in response to the defined environmental cues that 3 to 5 days, Id-3 after 3 days; GAPDH after 3 hours; and 28S after
stimulate normal hematopoietic growth and development. 15 to 30 minutes.
MATERIALS AND METHODS Isolation, Culture, and Analysis of Normal Murine Bone
Marrow and Fetal Liver CellsCell Lines and Cell Culture
Cells isolated from CBA/J bone marrow and day 12 fetal liverCell lines were cultured in medium alone, medium containing an
appropriate recombinant cytokine, or medium supplemented with were used in this work.
Progenitor studies (PR1 through PR40). Bone marrow cellsconditioned medium, as suitable for the individual cell lines. P3X,
Namalwa, EL-4, HL60, K562, MEL, WEHI 3, M1, and RAW 246.7 were plated in methylcellulose in the presence of IL-1, IL-3, SCF,
and erythropoietin for 27 hours. One or two cells from four to eightwere grown in RPMI 1640 supplemented with 10% heat-inactivated
fetal calf serum (HI-FCS); 18-81 and 22D6 were grown in the same cell colony starts were processed individually for RT-PCR. The
remaining sibling cells were transferred into individual secondarymedium supplemented with 50 mmol/L 2mercaptoethanol (2ME).
BW cells were grown in RPMI 1640 plus 20% FCS. T1165 were methylcellulose cultures containing the same cytokine supplement.
After 6 to 10 days, secondary colonies were picked, spread on glasscultured in RPMI 1640/10% HI-FCS supplemented with 5,000 U/
mL rIL-6 (R&D, Minneapolis, MN). HCD57 were grown in IMDM slides, and scored for content of various lineage on the basis of
May-Grunwald-Giemsa staining.plus 30% HI-FCS, 20 mmol/L 2ME and 0.3 U/mL erythropoietin
(Toyobo, New York, NY). M07E cells were cultured in DMEM/ Hematopoietic mature (HMI through HM20). CBA/J marrow
cells were grown under the conditions described above. Fifty to 15020% HI-FCS supplemented with 100 U/mL recombinant human
GM-CSF (R&D). MC6 cells were cultured in McCoy’s medium/ cells were taken for RT-PCR analysis after 6 to 8 days’ culture,
while the remaining cells were analyzed morphologically on glass10% FCS supplemented with amino acids, vitamins, and 10% WEHI
AID Blood 0024 / 5h34$$$462 04-02-97 14:24:25 blda WBS: Blood
 For personal use only. at UNIV OF MASSACHUSETTS on April 3, 2008. www.bloodjournal.orgFrom 
Id FAMILY REGULATORS IN HEMATOPOIESIS 3157
slides to confirm the lineage assignments. HM1 and HM2 were the cell lines become increasingly mature (Namalwa is a
sampled from growing, nonhemoglobinized erythroid precursors at mature B cell type derived from a Burkitt lymphoma, P3X
the BFU-E stage of maturation; HM3 and HM4 (erythroid) were is a myeloma, and T1165 is a hybridoma), Id-3 expression
taken from visibly hemoglobinized colonies; HM5 and HM6 (neutro- continues to drop. In P3X murine myeloma cells Id-3 is only
phil) were propagated in IL-3; HM7, HM8, HM15, and HM16 (mast)
expressed at 0.3% of its level in 18-81 murine pre-B cells.
were taken after 25 to 46 days bulk culture in IL-3; HM9 and HM10 This inverse relationship between Id-3 gene expression and(megakaryocytic) were amplified from single cells; HM11 and
B-cell differentiation stage is similar to that reported for Id-HM12 (day 12 fetal liver B220/) were from bulk cultures growing
1 in other cell types in which its expression declines duringin IL-7; HM13 and HM14 were bulk cultures of splenic T cells
forced differentiation of cell lines in vitro.23,26,28 Id-4 genegrowing in medium containing concanavalin A; HM17 and HM18
(macrophage) were cultured in IL-3 alone; and HM19 and HM20 expression was undetectable.
(macrophage) were cultured in IL-3 plus M-CSF.
The Id Family Genes Are Differentially Expressed During
the Early Stages of Normal Hematopoietic DevelopmentRT-PCR Analysis of Gene Expression in Single Cells and
Small Populations While examination of Id family gene expression in cell lines
provides an excellent foundation on which to base further studyIndividual cells picked from colony starts were analyzed by RT-
of these regulators, we also wished to examine earlier stagesPCR.4 For small pools of cells, RT-PCR was performed using prim-
ers and conditions as previously described.48 Five micrograms of of hematopoietic development in normal cells. To do this, we
each amplified product was separated by agarose gel electrophoresis used a unique culture system that allowed us to analyze gene
and transferred to Hybond N membrane. Each blot was subsequently expression in individual progenitor cells that have been ex-
probed with cDNA probes of the individual Id family genes. Due tracted from primitive colony starts. As a comparison and a
to the high degree of sequence conservation between human and
control, we also examined Id family gene expression in matur-
murine Id genes at both the DNA and protein levels (Id-1 mRNA, ing cells derived from normal bone marrow.83% identity at the DNA level; Id-2, 88%; Id-3, 86%), our murine
Hematopoietic progenitor cells. Murine bone marrowId probes were also effective for detection of human Id family
cells were plated in methylcellulose at low density in themRNAs. The Id-1 probe was a gift of H. Weintraub. pE:Id(S) is a
presence of a cytokine cocktail (IL-1, IL-3, SCF, and eryth-BamHI/EcoR1 fragment consisting of the total cDNA sequence from
ropoietin) that has been shown to support growth of thesepMH18DR blunt-ended into pEMSV-scribe a2 then released by
Sma I. The Id-2 probe was a gift of X-H. Sun and consisted of a cells.4 When individual colonies contained four to eight cells
BamHI/XhoI fragment consisting of the full-length Id-2 cDNA. they were separated and one or sometimes two cells were
Id-3 is a 0.94-kb EcoRI fragment originally cloned as h1h462 removed for single-cell RT-PCR amplification of their
(ATCC#63120). The Id-4 probes were a gift of F. Sablitzky: an mRNA. The remainder of the cells were separated in the
EcoRI fragment containing the ‘‘full’’ 1.7 kb cDNA sequence and dish and allowed to grow to maturity, when phenotype was
‘‘probe b,’’ an additional 0.7 kb of alternatively spliced Id-4, were
assigned by May-Grunwald-Giemsa staining. PCR-amplified
used. Finally, a rat GAPDH probe was used for normalization of
cDNA from 40 individual progenitor cells was assayed byloading efficiency and RNA integrity.5 The isolated fragments were
southern hybridization to Id family probes (Fig 2). The samerandom labeled to 0.5 to 1 1 109 cpm/mg and hybridized to the
samples probed in parallel with GAPDH serve as an RNAfilters at high stringency.48
integrity control for this experiment.
None of the Id family genes were highly expressed in theRESULTS
most primitive tripotential progenitors (PR1-PR5), which did
The Id Family Genes Are Widely Expressed in express significant levels of GAPDH, a housekeeping gene.
Hematopoietic Cell Lines However, in the slightly more mature bipotential and unipo-
tential precursors, Id-1 was widely expressed in a lineage-To determine the range of Id family gene expression in
hematopoietic cells, we initially analyzed a panel of 18 cell nonspecific manner (PR 6-40). While Id-2 may be expressed
at extremely low levels in all of the progenitor cells in thislines. These cells included both murine and human lymphoid
(P3X and T1165 plasmacytoma, Namalwa mature B, 22D6 study, high levels of its expression were limited to two uni-
potential progenitor cells, both of the macrophage lineageand 18-81 preB, and EL4 and BW T-cell lines), monocyte/
macrophage (M1 and RAW 246.7), megakaryotic (MO7E), (PR #23 and PR #30). Thus regulation of Id-1 and Id-2
gene expression does not appear to be coordinate in theerythroleukemia (K562 and MEL), mastocytoma (MC6), and
myeloid (WEHI-3, MC6, FDCP1, NFS60, HL60) cells. hematopoietic system as it has been reported for other tissue
types.27,49,50 Id-3 was clearly not expressed in any of the 40Id-1 gene expression was detected in most of the cell
lines examined (Fig 1A), although high level expression was progenitor cells examined here. However, it is important to
note that the culture conditions used for the generation ofrestricted to cells of the myeloid lineages (WEHI-3, NFS60,
and FDC-P1). Id-2 was more widely expressed than Id-1, the colony starts (ie, IL-1, IL-3, SCF, and erythropoietin)
favor development of the myeloid lineages at the expenseincluding strong expression in lymphoid cell lines of both
B- and T-cell origin, as well as in cells derived from the of lymphoid development.51 Therefore, it is possible that
expression of Id-3 would be upregulated during an earliermonocyte/macrophage lineages. The highest level of its ex-
pression was seen in the MC6 mastocytoma cell line. High phase of development, perhaps corresponding to an early
pre-B–cell precursor, if conditions promoting lymphoid de-level Id-3 gene expression was restricted to lymphoid cell
lines, especially those immortalized at early stages of B-cell velopment had been used in these cultures.
We also did not detect any expression of the Id-4 gene indevelopment (Fig 1C; 22D6 and 18-81 pre-B–cell lines). As
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Fig 1. Id family genes are widely expressed in he-
matopoietic cell lines. Expression of the four Id fam-
ily genes was assayed by Northern blot in total cellu-
lar RNA isolated from 18 murine and human
hematopoietic cell lines. Signal intensity was mea-
sured by phosphorimager before the blots were nor-
malized by rehybridization to a 28S RNA oligonucle-
otide. Values are comparable only within the group
of samples hybridized to a single probe; different
exposure times (Id-1 exposed for 24 hours, Id-2 ex-
posed for 120 hours, Id-3 exposed for 72 hours, and
28S RNA exposed for 30 minutes) were used for each
probe to maximize clarity of the phosphorimage.
Values were plotted as the relative intensity (pixel
number) of the specific bands above background for
each probe.
these progenitor cells. However, analysis of its expression of maturation. For example, eight cells were withdrawn from
bipotential colonies that later went on to produce neutrophilsmay be more complicated than the other three known Id
family genes, since it appears to be posttranscriptionally reg- and macrophages (PR 13-20). Only six of the eight colonies
produced high levels of Id-1 mRNA. We will show laterulated by alternative splicing.34 Two splice forms, 2.0 and
1.7 kb, predominate in the thymus, which is the only lympho- that Id-1 mRNA levels vary widely during cell cycle, so
perhaps this variation in gene expression merely reflects cellhematopoietic organ in which the differential expression of
Id-4 splice forms has been examined. We used two probes cycle position of the individual cells removed for analysis.
Alternatively, it may merely mean that the progenitors infor this work: one that preferentially detects the 1.7 and 2.0-
kb forms and one that hybridizes mainly to the 2.0-and 3.7- the colony are staggered with respect to maturation, with
some cells lagging slightly behind and not upregulating Id-kb form (and not the 1.7-kb form). Since the 5* and 3* termini
and all of the splice forms remain to be defined, it is difficult 1 expression yet. However, we also saw variations in
GAPDH and other housekeeping gene expression in theseto say whether we have exhausted the possibility that one
or more of the three Id-4 splice forms is actually expressed cells. There is some evidence to support the possibility that
mRNA transcription from individual templates proceeds inin hematopoietic cells during this phase of development.
Another notable finding in this work was the discordance an intermittent manner, so that the total level of mRNA
accumulation in a cell population reflects the number ofin gene expression among individual cells at the same stage
Fig 2. The Id family genes are differentially ex-
pressed during the early stages of normal hemato-
poietic development. Murine bone marrow was
plated in methylcellulose at low density in the pres-
ence of IL-1, IL-3, SCF, and erythropoietin, then al-
lowed to grow until individual colonies contained
four to eight cells. At that time, colonies were sepa-
rated and individual cells removed for single-cell
RT-PCR analysis of their gene expression. Five micro-
grams of the amplified product from 40 such progen-
itor cells was Southern blotted and probed with high
specific activity probes for each of the Id family genes
and for GAPDH. Phenotype was assigned by May-
Grunwald-Giemsa staining of the mature cells that
developed from each colony start. E, erythroid; Meg,
megakaryocytic; Mac, macrophage; Neut, neutro-
phil.
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strongly affected by cell cycle, with cells being most receptive
to differentiation signals during G1.54,55 Therefore, we wished to
test whether any/all of these Id family regulators might be in-
volved in the control of hematopoietic cell cycle progression at
the G1/S phase boundary.
To determine whether Id genes are modulated during the
G1 phase of the hematopoietic cell cycle, FDCP1 cells were
synchronized by isoleucine (ILE) deprivation then followed
through G1 and the S phase of one cell cycle. FDCP1 is a
nontransformed, cytokine-dependent cell line isolated after
long term culture of murine bone marrow56 that has retained
growth and cell cycle characteristics of a normal diploid
cell.57 After 36 hours of ILE deprivation in the presence of
cytokines, the cells have cycled back to a point in mid-G1
phase where they arrested in synchrony. Then, half of the
arrested cells were transferred into medium containing ILE
plus cytokines while the other half were transferred intoFig 3. Expression of Id family genes in mature hematopoietic cells.
Single lineage colonies derived from terminally maturing cells were medium containing ILE but lacking cytokines. These cells
divided: 50 to 150 cells were sampled by RT-PCR analysis and the were followed for 48 hours as indicated and Id family gene
remaining cells were analyzed morphologically on glass slides to
expression was measured by Northern blot and phosphorim-
confirm the lineage assignments. After southern transfer, the blots
age analysis. Synchronization was confirmed by followingwere probed at high stringency for the expression of individual Id
3H-thymidine uptake in the cytokine-replete, responsive pop-family genes and for GAPDH.
ulation during the course of the experiment.
Id-1 gene expression was high in the asynchronously pro-templates active at a given point in time rather than the sum
liferating log-phase cells, but it dropped off to less than 20%activity of all templates, which are constantly active.48,52,53
of the log-growing levels after 36 hours in medium lackingIf this were the case, then it would be possible to see all-or-
ILE but still containing the cytokines that would otherwisenone levels of gene expression in single cells drawn from
drive proliferation of these cells (Fig 4A and D). After re-colonies at the same stage of maturation. This interpretation
feeding the cells with complete medium containing WEH-is supported by the relative uniformity of gene expression
Icm, we saw a biphasic pattern of Id-1 gene expression: theamong pools of lineage-defined cells, where variations in
first peak at 2 hours being approximately twofold over thatsingle cell gene expression should be averaged out over the
seen in the growth-arrested cells; the second peak at 24 hourswhole population (Fig 3, below). Therefore, to interpret these
being a little over fourfold induction (solid bars). In thedata, we feel that is it most accurate and informative to
absence of exogenous cytokines, cells did not proliferate andassess gene expression at the ‘‘population’’ level, with gene
Id-1 expression was not induced (striped bars). Since detailedexpression within each group of like progenitors considered
cell cycle progression analysis of FDC-P1 shows that Stogether, rather than on an individual cell basis.
phase begins between 12 and 16 hours after release fromHematopoietic mature cells. Colonies or liquid cultures
isoleucine block,45 Id-1 gene expression first peaked in midnear maturity were assayed by RT-PCR and Southern blot (Fig
G1 then again during S phase: a transient decline in Id-1 gene3). In these maturing cells, Id-1, Id-2, and Id-3 were all ex-
expression occurs during transit of the late G1 checkpoint thatpressed, although again this expression was not coordinate.
regulates whether a cell continues to cycle and whether itWith the exception of the 2-day 12 fetal liver B220/ cultures
commits to differentiation.(HM 11 and 12), there was no absolute correlation between
Since Id-1 and Id-2 have been reported to be coordinatelyId-1 gene expression and cell lineage. However, when gene
regulated in several model systems, we were intrigued toexpression in the more primitive progenitor cells shown in Fig
find that Id-2 levels increased by a factor of five at the same2 was compared with these maturing colonies, there is a distinct
time Id-1 levels declined (Fig 4B and D). After refeeding
and inverse correlation between expression of Id-1, Id-2, and
with ILE-replete medium Id-2 levels declined transiently
cell maturation: with increasing maturity, levels of Id-1 expres-
whether cells were exposed to cytokines (solid bars) or not
sion declined and levels of Id-2 expression increased. High (striped bars), reaching log growth levels by 48 hours afterlevel Id-3 expression was restricted to the two fetal liver B220/
release from ILE block.
colonies (HM11 and 12), which mirrors its pattern of expres- We also stripped and reprobed these blots with Id-3 before
sion in the B-lymphoid cell lines shown in Fig 1. Again, Id-4
normalizing with 28S rRNA but no Id-3 mRNA was detectablegene expression was not detected. (not shown). Additional experiments with FDCP1 cells have
failed to reveal detectable levels of Id-3 or Id-4 gene expressionDifferential Expression of Id Family Genes During Cell Cycle (Fig 1), even using RT-PCR analysis (data not shown).
Id-1 has been shown to regulate differentiation by sequestering
Id-1 and Id-2 Are Differentially Regulated in Response toclass I HLH activators until they are required for differentiation
Cytokine Stimulation of FDCP1 Cellsto proceed. Certainly by preventing expression of lineage-specific
genes, Id-1 can play a role in preventing cellular differentiation. In the previous experiment, we demonstrated a biphasic
modulation of Id-1 levels as the cells traversed the G1 to SHowever, regulation of hematopoietic cell differentiation is
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Fig 4. Id-1 and Id-2 are differentially expressed during cell cycle.
Growth of FDCP1 cells was arrested in early G1 by isoleucine depriva-
tion. After 36 hours, half the cells were transferred into normal
growth medium (time ! 0), with 25% WEHIcm as a complex source
of cytokines (j), while the other half were transferred into fresh
medium without WEHIcm (
 
). Cells were allowed to grow for 48
hours, during which time samples were removed for RNA isolation
and northern hybridization to (A) Id-1 and (B) Id-2 probes. Signal
intensity was quantitated by phosphorimage analysis before the
blots were normalized by rehybridization to a 28S RNA oligonucleo-
tide. Values were plotted as the relative intensity (pixel number)
of the specific bands above background for each probe. Values are
comparable only within the group of samples hybridized to a single
probe; different exposure times were used for each probe to max-
imize clarity of the phosphorimage. (C) Cell cycle progression was
monitored by 3H-thymidine uptake of the cytokine-replete, proliferat-
ing population.
phase boundary. In the next set of experiments, we wishedto 0.05% HI-FCS) were transferred into medium containing
100 U/mL rmIL-3, 100 U/mL rmGM-CSF, or no recombi-determine if these changes were cytokine-responsive and/or
cytokine-specific. To do this, we again used FDCP1 cells nant cytokines (medium alone). Cells were cultured in 0.5%
HI-FCS plus/minus recombinant cytokines to minimize thewhich proliferate in response to IL-3 and GM-CSF. Cells
starved of cytokines for 24 hours in medium (RPMI 1640/ contribution of exogenous growth factors contributed by the
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Fig 4 (cont’d). (D) Raw data.
serum. This percentage of serum was determined by previous DISCUSSION
experimentation to be the minimum amount required to sup- Although the PHSC is a dormant (G0) cell,58-60 it retainsport viability of the unstimulated control cell population the capacity to respond to external signaling by entering
through the time course of this experiment (data not shown). cell cycle and continuing to proliferate until its progeny
After a 24-hour incubation without cytokines, cell growth differentiate into mature blood cells. For this to happen, gene
was arrested and Id-1 expression fell to undetectable levels. programs that maintain the quiescent state of the stem cell
However, its expression increased swiftly and dramatically need to be extinguished or modified and genes that support
within 2 hours of supplementation with rmIL-3, remaining proliferation must be induced. Later, the gene program that
elevated over the time course of the experiment (Fig 5A and supports proliferation of these undifferentiated progenitor
C). The biphasic pattern of Id-1 gene expression seen in this cells needs to be repressed and expression of a new set of
experiment is similar to that seen with ILE-synchronized differentiation-specific genes increased in turn. Candidate
cells (Fig 4A), which may reflect a partial synchronization regulators of this process must meet certain criteria: they
of these cells by the cytokine withdrawal. In contrast, Id-1 should be differentially expressed during a relevant period
gene expression was only slightly upregulated after treatment of development, respond to cytokine stimulation by appro-
with rmGM-CSF. The overall difference in Id-1 gene expres- priate up- or down-regulation of their expression, and partici-
sion between rmIL-3 and rmGM-CSF–treated FDCP1 cells pate in control of a developing cell’s ability to initiate and/
may signify that rmIL-3 more effectively induces Id-1 gene or maintain proliferation or to mediate terminal differentia-
expression and/or it may merely reflect the fact that FDCP1 tion. The Id family regulators of the HLH transcription factor
cells respond more quickly to rmIL-3 than to rmGM-CSF.57 family are excellent candidates for regulators of this process.
The pattern of Id-2 gene expression was somewhat differ- This is the first comprehensive study describing the expres-
ent (Fig 5B and C). Id-2 levels fell transiently over the first sion of the four Id family genes during growth and differenti-
8 to 10 hours after refeeding at the same time Id-1 gene ation in the hematopoietic system. Several important findings
expression was significantly upregulated (Fig 5A and C). In are revealed in this work: (1) Id-1 is not highly expressed
cells stimulated with rmIL-3, the levels of Id-2 remained until normal progenitors have matured to the bipotential and
low as the cells proliferated over the 24-hours course of this unipotential stage, after which time its expression decreases
experiment. In cells refed with medium plus 0.5% serum, the withmaturation; (2) Id-2 expression does not parallel that of
cells did not proliferate and the level of Id-2 gene expression Id-1 as it does in other tissue types; these two Ids are ex-
continued to rise. The rmGM-CSF—treated cells, which pressed reciprocally during growth and differentiation; and
responded with only minimal growth, showed an intermedi- (3) Id-2 and, to a limited extent, Id-3 are upregulated as cells
ate depression in Id-2 gene expression. A similar, reciprocal, mature.
pattern of Id-1 and Id-2 gene expression was also seen in In this work, we have observed that Id-1 levels decline
factor-starved NFS60 cells when compared with cells prolif- with differentiation (Figs 2 and 3) and with growth arrest of
erating in the presence of cytokines (Cooper, manuscript in proliferating cells (Figs 4 and 5), suggesting that Id-1 plays
preparation). Thus expression of Id-2 consistently runs a similar role during hematopoietic and nonhematopoietic
counter to that of Id-1, during periods of cytokine-stimulated development. Similar to its function during myogenesis, Id-
growth (Fig 5), cell cycle arrest (Figs 4 and 5), and during 1 controls the ability of erythroid, granulocytic, and B lym-
phocytes to differentiate.23,28,39 While Id-1 may inhibit differ-the differentiation process (Figs 2 and 3).
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Fig 5. Differential response of Id-1 and Id-2 to cy-
tokine stimulation in vitro. FDCP1 cells were starved
of cytokines for 24 hours, then transferred into fresh
medium (h) or medium containing 100 U/mL of ei-
ther rIL-3 (l) or rGM-CSF (j) at time zero. The cells
were allowed to grow for 24 hours, during which
time samples were removed for RNA preparation
and northern hybridization to (A) Id-1 and (B) Id-2
probes. Signal intensity was quantitated by phos-
phorimage analysis before the blots were normal-
ized by rehybridization to GAPDH. Values were plot-
ted as the relative intensity (pixel number) of the
specific bands above background for each probe.
Values are comparable only within the group of sam-
ples hybridized to a single probe; different exposure
times were used for each probe to maximize clarity
of the phosphorimage. (C) Raw data.
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entiation by preventing activation of lineage-specific genes, Multiple class I (E2A, E2-2, HEB) and class II (SCL/
it is also likely that expression of Id-1 promotes the G1 to S Tal-1, lyl-1) proteins are expressed during hematopoietic
phase transition as it does in nonhematopoietic cells. Regula- development. In most systems, it is a heterodimer between
tion of hematopoietic cell differentiation is strongly affected a class I and a tissue-specific class II gene that regulates a
by cell cycle position, with cells being most receptive to cell’s ability to differentiate.19 Our earlier work has shown
differentiation signals during G1.54,55 Cytokines that act to that the class II gene SCL/Ta1-1, a positive regulator of
arrest cells in G1 or to prolong this phase generally promote erythroid development as a heterodimer with the class I E2A
differentiation54,55,61-63 while conditions that shorten G1 lower proteins, is widely expressed in hematopoietic progenitors
the probability that differentiation will occur.55,64 Thus, as as is lyl-1.4 Many developmentally important genes have
Id-1 levels decline during normal development, the cell loses sequences homologous or closely related to the SCL/Tal-1
its capacity to progress, lingers in G1, and is therefore more and lyl-1 heterodimer preferred binding motifs: c-myb and
likely to be in the correct position to respond positively to the serum response element of c-fos, the promoter of MHC
differentiation signals from the bone marrow microenviron- class II Dra gene, pro-interleukin 1b promoter, g-globin
ment. enhancer, the erythroid promoters of the carbonic anhydrase
In nonhematopoietic tissues, Id-2 is coordinately ex- II, band 3 and GATA-1 genes, and the enhancer elements
pressed with Id-1 and also promotes cellular proliferation. of the immunoglobulin locus.42,72,73 While HLH class I/class
This is clearly not the case in hematopoietic cells, where III proteins have been demonstrated to be critical for expres-
expression of Id-2 seems to correlate with a state of quies- sion of immunoglobulin genes,74 the relative contribution of
cence rather than cell growth: Id-2 is highly expressed in HLH heterodimers to the expression of most lineage-specific
CD34/ human progenitor cells65 and Hoechtslo/Rhodaminelo genes remains to be determined.
stem cells (not shown), and in FDCP1 cells after cytokine This study has extended our earlier analysis of SCL, lyl-
starvation (Fig 5) or after growth arrest secondary to ILE 1, E2A, and Id-1 to a detailed examination of the dynamics of
deprivation (Fig 4). Because many hematopoietic lineages Id family gene expression in hematopoietic cells at different
undergo withdrawal from cell cycle at some point in the stages of development. Our findings support the hypothesis
differentiation process, the increase in Id-2 levels during that multiple members of the Id family will be important
hematopoietic differentiation (Fig 3) may also reflect a re- regulators of stem cell activation, progenitor growth, and the
duced proliferative capacity in these populations.66,67 The lineage differentiation process.
correlation of Id-2 expression with quiescence was an unex-
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